Immune modulating drug MP1032 with SARS-CoV-2 antiviral activity in vitro: A potential multi-target approach for prevention and early intervention treatment of COVID-19

Sara Schumann, Astrid Kaiser, Ferdinando Nicoletti, Katia Mangano, Paolo Fagone, Eduard van Wijk, Yu Yan, Petra Schulz, Beate Ludescher, Michael Niedermaier, Joerg von Wegerer, Pia Rauch, Christian Setz, Ulrich Schubert, Wolfgang Brysch
doi: https://doi.org/10.1101/2020.11.03.20216580
Back to top
Posted November 04, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Immune modulating drug MP1032 with SARS-CoV-2 antiviral activity in vitro: A potential multi-target approach for prevention and early intervention treatment of COVID-19
Sara Schumann, Astrid Kaiser, Ferdinando Nicoletti, Katia Mangano, Paolo Fagone, Eduard van Wijk, Yu Yan, Petra Schulz, Beate Ludescher, Michael Niedermaier, Joerg von Wegerer, Pia Rauch, Christian Setz, Ulrich Schubert, Wolfgang Brysch
medRxiv 2020.11.03.20216580; doi: https://doi.org/10.1101/2020.11.03.20216580
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area